Volume 25, Number 10—October 2019
Research
Sporotrichosis in the Highlands of Madagascar, 2013–20171
Table 2
Characteristic |
Sporotrichosis, no. (%), n = 63 |
Other, no. (%), n = 85 |
p value |
Recruitment period | 0.16† | ||
2013, from March 1 | 6 (9.6) | 10 (11.8) | |
2014 | 16 (25.4) | 12 (14.1) | |
2015 | 21 (33.3) | 26 (30.6) | |
2016 | 13 (20.6) | 23 (27.1) | |
2017, until May 31 |
7 (11.1) |
14 (16.4) |
|
Age range, y | 0.2‡ | ||
3–18 | 11 (17.5) | 6 (7.1) | |
19–33 | 15 (23.8) | 16 (18.8) | |
34–48 | 17 (27.0) | 30 (35.3) | |
49–63 | 12 (19.1) | 17 (20.0) | |
64–80 |
8 (12.7) |
16 (18.8) |
|
Sex | 0.29‡ | ||
M | 44 (69.8) | 67 (78.8) | |
F |
19 (30.2) |
18 (21.2) |
|
Lesion location | <0.0001‡ | ||
Leg | 30 (47.6) | 63 (74.2) | |
Arm | 31 (49.2) | 11 (12.9) | |
Other§ |
2 (3.2) |
11 (12.9) |
|
Occupation | 0.07‡ | ||
Farmer | 33 (52.4) | 43 (50.6) | |
Service sector | 8 (12.7) | 23 (27.1) | |
Student | 9 (14.3) | 11 (12.9) | |
Craftsman/tradesman | 10 (15.8) | 4 (4.7) | |
Unemployed |
3 (4.8) |
4 (4.7) |
|
Region of contamination | <0.0001‡ | ||
Highlands region | |||
Analamanga | 38 (60.3) | 18 (21.2) | |
Amoron’i Mania | 8 (12.7) | 4 (4.7) | |
Bongolava | 3 (4.8) | 0 (0) | |
Itasy | 6 (9.5) | 3 (3.5) | |
Vakinankaratra | 7 (11.1) | 3 (3.5) | |
Other | 1 (1.6)¶ | 57 (67.1) |
*Mean (±SD) ages: sporotrichosis patients 38.1 (±19.5); other patients, 43.2 (±18.1); p = 0.10 (Student t test p value to compare mean age between both groups).
†χ2 test for trend.
‡χ2 or Fisher exact test to compare categorical variables between both groups.
§On trunk, leg and arm, or leg and thorax.
¶Localized to Atsinanana.
1Preliminary results from this study were presented at the 20th ISHAM Conference; June 29–July 5, 2018; Amsterdam, the Netherlands (abstract no. S1.4d).
Page created: September 17, 2019
Page updated: September 17, 2019
Page reviewed: September 17, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.